ThunyFGrisoliDCollartFHabibGRaoultD. Management of infective endocarditis: challenges and perspectives. Lancet2012; 379: 965–975.
2.
HabibG. Management of infective endocarditis. Heart2006; 92: 124–130.
3.
Diller GP, Baumgartner H. Endocarditis in adults with congenital heart disease: new answers-new questions. Eur Heart J 2017 Feb 23. [Epub ahead of print].
4.
Kuijpers JM, Koolbergen DR, Groenink M, et al. Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: focus on the use of prosthetic material. Eur Heart J. 2017 Jan 8. pii: ehw591. [Epub ahead of print].
5.
YanagawaBPetterssonGBHabibG. Surgical management of infective endocarditis complicated by embolic stroke. Practical recommendations for clinicians. Circulation2016; 134: 1280–1292.
6.
ChambersJBRaySPrendergastB. Specialist valve clinics: recommendations from the British Heart Valve Society working group on improving quality in the delivery of care for patients with heart valve disease. Heart2013; 99: 1714–1716.
7.
ChambersJSandoeJRayS. The infective endocarditis team: recommendations from an international working group. Heart2014; 100: 524–527.
8.
HabibGLancellottiPAntunesMJ. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J2015; 36: 3075–3128.
9.
NishimuraRAOttoCMBonowRO. ACC/AHA Task Force Members. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation2014; 129: e2440–e2492.
10.
Botelho-NeversEThunyFCasaltaJP. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med2009; 169: 1290–1298.
11.
ChirilloFScottonPRoccoF. Impact of a multidisciplinary management strategy on the outcome of patients with native valve infective endocarditis. Am J Cardiol2013; 112: 1171–1176.
12.
Carrasco-ChinchillaFSanchez-EspınGRuiz-MoralesJ. Influence of a multidisciplinary alert strategy on mortality due to left-sided infective endocarditis. Rev Esp Cardiol (Engl Ed)2014; 67: 380–386.
13.
MestresCAParéJCMiróJM. Working Group on Infective Endocarditis of the Hospital Clinic de Barcelona. Organization and functioning of a multidisciplinary team for the diagnosis and treatment of infective endocarditis: a 30-year perspective (1985–2014). Rev Esp Cardiol (Engl Ed)2015; 68: 363–368.
14.
DanielDSLeeSMDykesGARahmanS. Public health risks of multiple-drug-resistant Enterococcus spp. in Southeast Asia. Appl Environ Microbiol2015; 81: 6090–6097.
15.
LeeCHTsaiWCLiuPY. Epidemiologic features of infective endocarditis in Taiwanese adults involving native valves. Am J Cardiol2007; 100: 1282–1285.
16.
MurdochDRCoreyGRHoenB. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med2009; 169: 463–473.
17.
OkitaYMinakataKYasunoS. Optimal timing of surgery for active infective endocarditis with cerebral complications: a Japanese multicentre study. Eur J Cardiothorac Surg2016; 50: 374–382.
18.
SakamotoTKanoHMiyaharaS. Efficacy of nafamostat mesilate as anticoagulation during cardiopulmonary bypass for early surgery in patients with active infective endocarditis complicated by stroke. J Heart Valve Dis2014; 23: 744–751.
19.
JovinTGChamorroACoboE. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med2015; 372: 2296–2306.
